RepliCel Life Sciences Inc  

(Public, OTCMKTS:REPCF)   Watch this stock  
Find more results for OTC:REPCF
-0.04 (-3.18%)
Feb 17 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 1.14 - 1.24
52 week 0.43 - 1.67
Open 1.24
Vol / Avg. 25,567.00/13,612.00
Mkt cap 34.04M
P/E     -
Div/yield     -
EPS 0.00
Shares 54.08M
Beta 1.31
Inst. own     -

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin - -0.69%
Operating margin - 12.96%
EBITD margin - 13.11%
Return on average assets -157.09% -2.23%
Return on average equity -206.62% -3.82%
Employees 4 -
CDP Score - -


Suite 1225, 888 Dunsmuir Street
+1-604-2488730 (Phone)
+1-604-2488690 (Fax)

Website links


RepliCel Life Sciences Inc. (RepliCel), formerly Newcastle Resources Ltd. is a Canada-based company, engaged in the business of developing and patenting hair follicle cell replication technology. The Company’s cellular replication and implantation technology is designed to rejuvenate damaged, miniaturized hair follicles in balding scalp skin. The Company is developing an autologous cell-based procedure for the treatment of androgenetic alopecia (pattern baldness) and general hair loss in men and women. It is focused on ensuring the safety and demonstrating the efficacy of RepliCel’s cell-based hair regeneration procedure in humans. As of September 30, 2012, the Company‘s subsidiary included TrichoScience Innovations Inc. (TrichoScience).

Officers and directors

Peter K. Jensen Chairman of the Board
Age: 61
David M. Hall President, Chief Executive Officer, Director
Age: 59
Thomas A. Kordyback C.A. Chief Financial Officer
Age: 61
Kevin McElwee Ph.D. Chief Scientific Officer
Age: 43
Gemma Fetterley Vice President - Finance, Treasurer, Secretary
Age: 34
Darrell Panich Vice President - Clinical Affairs
Age: 41
Rolf Hoffmann M.D. Chief Medical Officer, Director
Age: 51
John Challis Director
Age: 66
Peter W. Lewis C.A. Independent Director
Age: 57